Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 20
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Applying principles of patient blood management during COVID-19 pandemic: a literature review | Khandelwal A, Vandermeulen H, Tordon B, Pavenski K | 2022 | Annals of Blood | View Applying principles of patient blood management during COVID-19 pandemic: a literature review | Health care providers | Clinical research |
NAC Statement on RHD Genotyping in Prenatal Patients | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View NAC Statement on RHD Genotyping in Prenatal Patients | Health care providers | Benchmarking and standard setting |
Babesia microti in a Canadian blood donor and lookback in a red blood cell recipient | Drews SJ, Van Caeseele P, Bullard J, Lindsay LR, Gaziano T, Zeller MP, Lane D, Ndao M, Allen VG, Boggild AK, O'Brien SF, Marko D, Musuka C, Almiski M, Bigham M | 2022 | Vox Sang | View Babesia microti in a Canadian blood donor and lookback in a red blood cell recipient | Health care providers | Clinical research |
Hemolysis after high-dose intravenous immunoglobulin: An under-appreciated sequelae | Branch DR, Almizraq RJ, Bussel JB | 2022 | Am J Hematol | View Hemolysis after high-dose intravenous immunoglobulin: An under-appreciated sequelae | Researchers | Basic research |
Prolonged Blood Storage and Risk of Posttransfusion Acute Kidney Injury | Adegboye J, Sapatnekar S, Mascha EJ, Shah K, Lioudis M, Essber H, Cohen B, Rivas E, Heddle NM, Eikelboom JW, Ellis MH, Sharon Y, Sinha R, Kurz A, Sessler DI | 2022 | Anesthesiology | View Prolonged Blood Storage and Risk of Posttransfusion Acute Kidney Injury | Researchers | Clinical research |
Chapter 19. Pathogen-reduced platelets | Blais-Normandin I, Tordon B, Anani W, Ning S | 2022 | Clinical Guide to Transfusion | View Chapter 19. Pathogen-reduced platelets | Health care providers | Benchmarking and standard setting |
Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic | Drews SJ, O’Brien SF | 2022 | Viruses | View Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic | Blood operators | New or improved product or process |
A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors | Holloway K, Campbell C, Ali R, Huyer LD, Hart D, Haw J, Brennenstuhl S, Grundy Q | 2022 | Transfus Med | View A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors | Researchers | Ethical, legal & social implications research |
Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude | Li M, Tang X, Liao Z, Shen C, Cheng R, Fang M, Wang G, Li Y, Tang S, Xie L, Zhang Z, Kamau PM, Mwangi J, Lu Q, Li Y, Wang Y, MacKeigan DT, Cerenzia EG, Ni H, Lai R | 2022 | Blood | View Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude | Researchers | Basic research |
RE: A better normal in Canada will need a better detection system for emerging and re-emerging respiratory pathogens | O'Brien S, Goldman M, Drews S | 2022 | CMAJ | View RE: A better normal in Canada will need a better detection system for emerging and re-emerging respiratory pathogens | Researchers | Clinical research |
Contamination of platelet concentrates with Staphylococcus aureus induces significant modulations in platelet functionality | Yousuf B, Pasha R, Pineault N, Ramirez-Arcos S | 2022 | Vox Sang | View Contamination of platelet concentrates with Staphylococcus aureus induces significant modulations in platelet functionality | Researchers | Basic research |
ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men | Walsh G | 2022 | Blood.ca website | View ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men | Regulators | MSM research |
Inductively-Coupled Plasma Mass Spectrometry-Novel Insights From an Old Technology Into Stressed Red Blood Cell Physiology | Stephenson D, Nemkov T, Qadri SM, Sheffield WP, D'Alessandro A | 2022 | Front Physiol | View Inductively-Coupled Plasma Mass Spectrometry-Novel Insights From an Old Technology Into Stressed Red Blood Cell Physiology | Researchers | Basic research |
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Olasupo OO, Haddix C, Nakar C, Maahs J, Greist A, Ghafoor A, Donfield SM, Iorio A, Shapiro AD | 2022 | Eur J Haematol | View Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Health care providers | Benchmarking and standard setting |
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Caffrey N, Goldman M, Osmond L, Yi Q-L, Fan W, O'Brien SF | 2022 | Transfusion | View HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Regulators | MSM research |
Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Balitsky A, Arnold D | 2022 | Transfusion | View Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Health care providers | Clinical research |
A cross-sectional study of haemolytic disease of the newborn in Uganda | Dhabangi A, Nankunda J, Okaba V, Nakubulwa S, Hume HA, Dzik WH, Heddle NM | 2022 | Vox Sang | View A cross-sectional study of haemolytic disease of the newborn in Uganda | Health care providers | Clinical research |
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Hillis C, Vicente C, Ball G | 2022 | Pharmacoeconomics | View The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Researchers | Clinical research |
The Missing Pieces to the Cold-Stored Platelet Puzzle | Zhao H, Devine DV | 2022 | Int J Mol Sci | View The Missing Pieces to the Cold-Stored Platelet Puzzle | Researchers | Basic research |
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Qi X, Hatami S, Bozso S, Buchko M, Forgie KA, Olafson C, Khan M, Himmat S, Wang X, Nobes DS, Acker JP, Nagendran J, Freed DH | 2022 | J Heart Lung Transplant | View The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Researchers | Basic research |
Summary of adverse transfusion reactions 2017-2022 | Yan M | 2022 | Blood.ca website | View Summary of adverse transfusion reactions 2017-2022 | Blood operators | Benchmarking and standard setting |
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies | Maganti HB, Kirkham AM, Bailey AJM, Shorr R, Kekre N, Pineault N, Allan DS | 2022 | Cytotherapy | View Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies | Researchers | Clinical research |
The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update | Kamel H, Ramirez-Arcos S, McDonald C, ISBT Transfusion-Transmitted Infectious Disease Bacterial Working Party Bacterial Subgroup | 2022 | Vox Sang | View The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update | Researchers | Benchmarking and standard setting |
Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources | Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, Warkentin TE | 2022 | J Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources | Health care providers | Clinical research |
Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination | Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME | 2022 | J Immunol | View Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination | Health care providers | Clinical research |
THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets | Gil Gonzalez L, Fernandez-Marrero Y, Norris PAA, Tawhidi Z, Shan Y, Cruz-Leal Y, Won KD, Frias-Boligan K, Branch DR, Lazarus AH | 2022 | PLoS One | View THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets | Researchers | Basic research |
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia | Karnes JH, Rollin J, Giles JB, Martinez KL, Steiner HE, Shaffer CM, Momozawa Y, Inai C, Bombin A, Shi M, Mosley JD, Stanaway I, Selleng K, Thiele T, Mushiroda T, Pouplard C, Heddle NM, Kubo M, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM | 2022 | Blood | View ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia | Researchers | Basic research |
Preparing small-dose red cell concentrates (RCCs) for neonatal and pediatric transfusions: Impact of RCC volume, storage, and irradiation | Olafson C, William N, Howell A, Beaudin L, Gill B, Clarke G, Stephens S, Lopes-Carvalho D, Lane D, Schubert P, McTaggart K, Acker JP | 2022 | Transfusion | View Preparing small-dose red cell concentrates (RCCs) for neonatal and pediatric transfusions: Impact of RCC volume, storage, and irradiation | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Health care providers | Benchmarking and standard setting |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Drews S, Devine D, McManus J, Mendoza E, Manguiat K, Girardin R, Dupuis A, McDonough K, Lin J, Evans D, Pambrun C, Drebot M, Wood H | 2022 | Transfus Med Rev | View Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Blood operators | New or improved product or process |
Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Boligan KF, Sandhu G, Branch DR | 2022 | Curr Protoc | View Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Researchers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Relevé des maladies transmissibles au Canada | View Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies | Gajic-Veljanoski O, Li C, Schaink AK, Guo J, Shehata N, Charames GS, de Vrijer B, Clarke G, Pechlivanoglou P, Okun N, Kandel R, Dooley J, Higgins C, Ng V, Sikich N | 2022 | Transfusion | View Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies | Researchers | Clinical research |
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Aubé E, Lewin A, O'Brien SF, Grégoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Seed CR, Camirand Lemyre F, the Surveillance RA, Policy Subgroup of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Blood operators | MSM research |
The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Asamoah-Boaheng M, Goldfarb DM, Karim ME, O’Brien SF, Wall N, Drews SJ, Barakauskas V, Jassem AN, Grunau B | 2022 | J Infect Dis | View The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Researchers | Clinical research |
HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Lambert G, Cox J, Fourmigue A, Dvorakova M, Apelian H, Moodie EEM, Grace D, Skakoon-Sparling S, Moore DM, Lachowsky N, Jollimore J, Lal A, Parlette A, Hart TA | 2022 | Transfusion | View HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Researchers | MSM research |
Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study | Trépanier P, Fournier D, Simard C, Fontaine MJ, Stroncek D, Takanashi M, McKenna D, Schwartz J, Tanhehco YC, Reems J-A, Torrents S, Kogler G, Liedtke S, Giroux M, Holovati JL, Louis I, Prasath A, Pineault N, Bazin R, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Transfusion | View Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study | Researchers | Benchmarking and standard setting |
A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Armstrong JP, Brennan DJ, Collict D, Kesler M, Bekele T, Souleymanov R, Grace D, Lachowsky NJ, Hart TA, Adam BD | 2022 | BMC Public Health | View A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Researchers | MSM research |
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Castillo G, Vesnaver E, Gibson E, Butler-Foster T, Goldman M, Hill NE, Rosser A, Lapierre D, Rubini KA, MacDonagh R, Miguel G, Palumbo A, MacPherson P, Randall T, Osbourne-Sorrell W, O'Brien SF, Bridel W, Otis J, Greaves M, Al-Bakri TB, Reid M, Labrecque M, Germain M, Orvis S, Clapperton AT, Devine D, Presseau J | 2022 | Transfusion | View Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Blood operators | MSM research |
A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM | 2022 | Ann Emerg Med | View A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Researchers | Clinical research |
Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Health care providers | Benchmarking and standard setting |
Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Shopsowitz KE, Lim C, Shih AW, Fishbane N, Berry BR, Bigham M, Petraszko T, Trudeau J, Wyatt M, Yan MTS, Morrison D | 2022 | Vox Sang | View Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Blood operators | Benchmarking and standard setting |
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Drews SJ, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Yi Q-L, O’Brien SF, Mostafa HH | 2022 | Microbiol Spectr | View SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Researchers | Clinical research |